Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
133.67
+11.39 (9.31%)
Jun 16, 2025, 3:58 PM - Market open
Nutex Health Stock Forecast
Stock Price Forecast
The 2 analysts that cover Nutex Health stock have a consensus rating of "Strong Buy" and an average price target of $262.5, which forecasts a 96.38% increase in the stock price over the next year. The lowest target is $225 and the highest is $300.
Price Target: $262.5 (+96.38%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Nutex Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $100 → $225 | Strong Buy | Maintains | $100 → $225 | +68.32% | May 20, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $150 → $300 | Strong Buy | Maintains | $150 → $300 | +124.43% | May 15, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $75 → $100 | Strong Buy | Maintains | $75 → $100 | -25.19% | Apr 8, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $50 → $75 | Strong Buy | Maintains | $50 → $75 | -43.89% | Feb 13, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $45 → $50 | Strong Buy | Maintains | $45 → $50 | -62.59% | Nov 12, 2024 |
Financial Forecast
Revenue This Year
795.83M
from 479.95M
Increased by 65.82%
Revenue Next Year
835.48M
from 795.83M
Increased by 4.98%
EPS This Year
5.53
from 9.71
Decreased by -43.01%
EPS Next Year
4.55
from 5.53
Decreased by -17.79%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 851.6M | 909.3M |
| Avg | 795.8M | 835.5M |
| Low | 734.5M | 756.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 77.4% | 14.3% |
| Avg | 65.8% | 5.0% |
| Low | 53.0% | -4.9% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 11.13 | 8.42 |
| Avg | 5.53 | 4.55 |
| Low | 0.25 | 0.88 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | 14.6% | 52.2% |
| Avg | -43.0% | -17.8% |
| Low | -97.5% | -84.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.